Business · 09/02/1998Updated: 10/17/2026 · 1 min read
FDA Approves UroLume Endourethral Prostatic Device for Prostatic Obstruction
Summary
The US Food and Drug Administration (FDA) has approved a device by American Medical Systems Inc. for treating prostatic obstruction caused by benign prostatic hypertrophy (BPH), following a recommendation by a panel of experts.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →